XJPX
4967
Market cap2.55bUSD
Jul 10, Last price
5,545.00JPY
1D
-2.57%
1Q
-6.19%
Jan 2017
10.90%
Name
Kobayashi Pharmaceutical Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Osaka, Japan, and established in 1886, Kobayashi Pharmaceutical Co., Ltd. is a global enterprise specializing in the development, manufacturing, and distribution of a wide array of consumer products. Its extensive offerings span key categories including healthcare, household necessities, skincare, and personal warming items. The company is recognized for a variety of popular brands such as Ammeltz (a topical pain reliever), Inochi no Haha (a women's health remedy), Sarasaty (lingerie soap), and Bluelet Decoral (a toilet cleaner and freshener). Their product lineup further includes Naishitol (a traditional Chinese medicine), Eaude Muge (an anti-acne medicated lotion), dental hygiene items like Itoyoji floss picks and BreathCare capsules, and eye care solutions such as Eyebon eye wash and Netsusama cooling gel sheets. Air fresheners like Sawaday and general deodorizing products, lens cleaners, and other oral hygiene items also form part of their portfolio. Beyond these, the company manufactures pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products. They also market nutritional supplements and skincare directly through online and telephone channels. Complementing its core business, Kobayashi Pharmaceutical is involved in various other activities, including transportation, real estate management, advertising planning and production, and asset management.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||